Hyperion Capital Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.65M Sell
71,476
-69,373
-49% -$5.9M 2.55% 12
2026
Q1
$12.1M Sell
140,849
-6,008
-4% -$539K 5.84% 5
2025
Q4
$12.8M Buy
+146,857
New +$11.1M 6.28% 6

Other funds holding GMED

Hyperion Capital Advisors's GMED Position: Q2 2026 in Review

Hyperion Capital Advisors reduced its Globus Medical (GMED) stake by 49% in Q2 2026, selling an estimated $5.9M and leaving 71,476 shares worth $5.65M. The position accounts for 2.55% of the portfolio, ranked #12.

Hyperion Capital Advisors first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.8M in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Hyperion Capital Advisors held 71,476 shares of Globus Medical worth $5.65M as of Q2 2026.
  • Hyperion Capital Advisors sold 69,373 Globus Medical shares in Q2 2026, an estimated $5.9M.
  • Globus Medical made up 2.55% of Hyperion Capital Advisors's portfolio in Q2 2026, its #12 holding.
  • Hyperion Capital Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Hyperion Capital Advisors's Globus Medical position peaked at $12.8M in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Hyperion Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.